 |
인쇄하기
취소
|
Taejoon Pharm wins patent lawsuit against GE Healthcare
The Supreme Court ruled that Taejoon Pharm did not used patent-covered injection technology of contrast media developed by General Electric Healthcare, ending a three-year-long legal battle between the Korean firm and the U.S. company.
In the ruling, the court said that Taejoon has not infringed on the patent of GE Healthcare, confirming the company is the patent holder of the technology inv...
In the ruling, the court said that Taejoon has not infringed on the patent of GE Healthcare, confirming the company is the patent holder of the technology inv...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.